financial estimates

Quanterix Projects Q4 2021 Revenues of $29M to $31M

The company projected full year 2021 revenues of $109 million to $111 million, up from $86.4 million in 2020.

Accelerate Diagnostics CEO Lays Out Plans at JP Morgan Healthcare Conference

The company said that it contracted 16 Pheno instruments with new US customers during Q4 and ended 2021 with 81 instruments in its US backlog.

Danaher, PerkinElmer, Cue Health, Others Announce Preliminary Q4 Earnings Results

Other companies reporting preliminary Q4 financial results included Fluidigm, SomaLogic, and T2 Biosystems.

Exact Sciences Projects up to $475M in Q4 Revenues, Acquires Testing Lab, Inks Licensing Deal

The approximately 2 percent increase over Q4 2020 results beat analysts' expectations, and the acquisition news heralds market expansion into hereditary cancer testing.

Quidel Preliminary Q4 Revenues Drop 21 Percent, Beat Estimates

For the fourth quarter of 2021, the firm expects COVID-19 revenues of approximately $510 million and total revenues of $633 million to $637 million.

Oct 8, 2021

Quidel Preliminary Q3 Revenues Rise, Easily Beat Analysts' Estimate

Aug 5, 2021

Chembio Diagnostics Q2 Revenues Rise 27 Percent; Firm Conducts Going Concern Evaluation

Jul 26, 2021

PerkinElmer to Acquire BioLegend for $5.25B; Q2 Revenues Rise 51 Percent

Jul 19, 2021

Natera Reports Preliminary Q2 Revenue Growth of Around 60 Percent

Jul 13, 2021

Meridian Bioscience Fiscal Q3 Preliminary Revenues Drop 25 Percent

Jul 12, 2021

Qiagen Reports Preliminary Q2 Revenues Above Guidance; Adjusts FY21 Expectations Downward

May 5, 2021

Ortho Clinical Diagnostics Q1 Revenues Rise 24 Percent on Core Revenue Strength

Apr 23, 2021

Quidel Preliminary Q1 Revenues Double But Fall Far Short of Expectations

Apr 5, 2021

HTG Molecular Preliminary Q1 Revenues Fall 56 Percent

Apr 1, 2021

360Dx Index Declines 2 Percent in March, Continuing Downward Slope

Mar 16, 2021

Exagen Q4 2020 Revenues Up 24 Percent, Full Year Revenues Grow 4 Percent

Feb 11, 2021

LabCorp Q4 Revenues Rise 52 Percent

Feb 5, 2021

Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent

Feb 2, 2021

PerkinElmer Q4 Revenues Spike 68 Percent

Feb 1, 2021

Fulgent Genetics, Genetron Pace Stock Price Increases as 360Dx Index Rises 10 Percent to Start 2021

Jan 14, 2021

JP Morgan Healthcare Conference, Day 3: Exact Sciences, Luminex, Danaher, Siemens Healthineers, and More

Jan 13, 2021

Quanterix Provides Preliminary Results Projecting Q4 Revenues of $24M to $26M